GlassScriptPhysician profile
Ling Huang
NPI 1053930735
$3,140.63
in general payments reported to CMS, 2019-2025
6 companies · $280 in 2025
The $280 reported for 2025 was less than what a typical Hematology & Oncology provider received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $299 · 2024: $2,562 · 2025: $280.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $2,291 · Food and Beverage: $674 · Education: $176.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $2,290.94 |
| Food and Beverage | $673.75 |
| Education | $175.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sobi, INC | $2,488.46 | 2024-2025 | |
| Genzyme Corporation | $338.41 | 2024-2025 | |
| Cti Biopharma Corp. | $122.78 | 2023 | Vonjo |
| Incyte Corporation | $90.95 | 2023 | |
| Janssen Biotech, INC. | $84.99 | 2023 | Rybrevant |
| Hema Biologics, LLC | $15.04 | 2025 | Sevenfact |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ling Huang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.